Views & Analysis The NHS, new models of care and STPs: what role for pharma? These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.
Views & Analysis Just unveiled, the next big idea for England’s NHS Trailblazing ‘Accountable Care Systems’ announced in England to integrate health and social care.
Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
Views & Analysis How will STPs change the face of the NHS in 2017? What changes will STPs bring and what are the implications for pharma?
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.